#open-heart-surgery

#open-heart-surgery

Some 1 million patients in the U.S. live with a type of heart disease called heart failure with preserved ejection fraction, or HFpEF, caused by a stiffening of a chamber of the heart that makes it much more challenging to distribute blood throughout the body. The condition has few approved therapies and high mortality rates.

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

As you age, inactivity can lead to a variety of cardiovascular problems, one of which involves stiffening of the heart's left ventricle. That's the chamber responsible for pumping oxygen-rich blood to the rest of the body. According to Dr. Benjamin Levine , Director of the Institute and Professor of Internal Medicine at University of Texas Southwestern (UTSW), "When the muscle stiffens, you get high pressure and the heart chamber doesn't fill as well with blood."

It may have started earlier, but it came to a head in the middle of the night in the middle of London in the middle of last November, when former Tour de France green jersey winner Sam Bennett woke up with a weird sensation in his chest. His heart rate was unusually high for somebody who had been asleep a few moments earlier, let alone for a professional athlete with a resting heart rate in the low 40s.

He has been living with atrial fibrillation (AF), a common heart rhythm problem, affecting 1.4m people in the UK, that can cause your heart to beat irregularly and often too fast. "It's very debilitating. On my worst day I feel very tired, my heart rate increases rapidly - I could walk for 2 or 3 miles and be okay, I could walk for 100 yards and it would hit me."

A common diabetes medication does not help people with peripheral artery disease (PAD) and without diabetes walk farther, according to results from a major U.S. clinical trial published in JAMA. Peripheral artery disease (PAD) is a serious condition that affects blood flow to the legs, making walking painful and difficult. It impacts approximately 12 million adults in the U.S. and is linked to higher risks of heart attack and stroke.

Adults who sleep fewer than seven hours each night are more likely to experience health problems.

Male, 56 years old, resident of CastillaLa Mancha He had already undergone a heart transplant at the 12 de Octubre Hospital in August 2017. After an initially good evolution during the first years, his new heart began to deteriorate progressively and did not respond to any of the therapeutic measures used. He was placed on the waiting list for a retransplant in August 2024.

When Dr. Homoud Aldahash started the three-hour process of removing a tumor about the size of a walnut from a patient's brain, it was an experience unlike any other in his 25 years as a neurosurgeon. It wasn't Aldahash's gloved hands slicing 68-year-old Mohammed Almutrafi's right frontal lobe, but surgical instruments attached to a set of robotic arms, which Aldahash controlled from a console where he sat three meters away.